分子靶向治疗在肺鳞癌中的研究进展
Explore this paper's citation graph
Summary
The future of lung cancer research is under threat, according to new research.
- Type
- review
- Published
- 2013-12-01
- Cited by
- 0
- References
- 36
- Access
- Open access
- OpenAlex
- https://openalex.org/W71673545
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:214597813
Keywords
Discoidin domain, Epidermal growth factor receptor, Lung cancer, Cancer research, Anaplastic lymphoma kinase
References
- Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas.
- High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
- Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
- DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma
- SOX2 in squamous cell carcinoma: Amplifying a pleiotropic oncogene along carcinogenesis
- PIK3CA mutation and amplification in human lung cancer
- Clinicopathological correlations of mTOR and pAkt expression in non-small cell lung cancer
- Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
- SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
- PIK3CA mutation status in Japanese lung cancer patients.
- Rarity of AKT1 and AKT3 E17K mutations in squamous cell carcinoma of lung
- A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer
- Pathology of lung cancer.
- Evidence That SOX2 Overexpression Is Oncogenic in the Lung
- EGFRvIII mutation in lung cancer correlates with increased EGFR copy number.
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
- Abnormalities of epidermal growth factor receptor in lung squamous‐cell carcinomas, adenosquamous carcinomas, and large‐cell carcinomas
Cited by
No citing papers recorded for this paper.
Related papers
- Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer
- Association of cytokines levels with epidermal growth factor receptor mutation in lung cancer patients
- The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
- Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer
- Molecular triage of lung cancer for targeted therapy
- Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer.
- 晚期非小细胞肺癌ALK融合基因及其他少见驱动基因阳性靶向治疗进展
- Imaging on Lung Cancer and Treatment with Targeted Therapy.
- Advances in EGFR-targeted therapy of non-small cell lung cancer